Quantification of cellular adhesion molecules on malignant B cells from non-Hodgkin's lymphoma

Leukemia

Volumn 13, Issue 9, 1999, Pages 1428-1433

  Jacob, M C ^a,b,e   Agrawal, S ^c   Chaperot, L ^a,b   Giroux, C ^a   Gressin, R ^b,d   Le Marc'Hadour, F ^d   Favre, M ^a   Sotto, J J ^b,d   Bensa, J C ^a,b   Plumas, J ^a,b  

^a ETS Isere Savoie   (France)

^b Research Group on Lymphomas   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d GRENOBLE UNIVERSITY HOSPITAL   (France)

^e Laboratoire d'Immunocytologie   (France)

Author keywords

Adhesion molecules; Flow cytometry; Non Hodgkin's lymphoma; Quantification

Indexed keywords

ALPHA4 INTEGRIN; BETA1 INTEGRIN; CELL ADHESION MOLECULE; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; UNCLASSIFIED DRUG;

ADULT; ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LARGE CELL LYMPHOMA; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MANTLE CELL LYMPHOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; TUMOR GROWTH;

EID: 0032842481     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401517     Document Type: Article

References (47)

1. Hogg N, Berlin C. Structure and function of adhesion receptors in leukocyte trafficking. Immunol Today 1995; 16: 327-329.
2. Koopman G, Parmentier HK, Schuurman HJ, Newman W, Meijer CJLM, Pals ST. Adhesion of human B cells to follicular dendritic cells involves both the lymphocyte function-associated antigen 1/intercellular adhesion molecule 1 and very late antigen 4/vascular cell adhesion molecule 1 pathways. J Exp Med 1991; 173: 1297-1304.
3. Sen J, Bossu P, Burakoff SJ, Abbas AK. T cell surface molecules regulating non-cognate B lymphocyte activation. Role of CD2 and LFA-1. J Immunol 1992; 148: 1037-1042.
4. Springer TA. Adhesion receptors of the immune system. Nature 1990; 346: 425-434.
5. Thomas X, Campos L, Archimbaud E, Shi ZH, Treille-Ritouet D, Anglaret B, Fiere D. Surface marker expression in acute myeloid leukaemia at first relapse. Br J Cancer 1992; 81: 40-44.
6. Gorski A. The role of cell adhesion molecules in immunopathology. Immunol Today 1994; 15: 251-255.
7. Qian F, Vaux DL, Weissman IL. Expression of the integrin α4β1 on melanoma cells can inhibit the invasive stage of metastasis formation. Cell 1994; 77: 335-347.
8. Stauder R, Greil R, Schulz TF, Thaler J, Gattringer C, Radaskiewicz T, Dierich MP, Huber H. Expression of leucocyte function-associated antigen-1 and 7F7-antigen, an adhesion molecule related to intercellular adhesion molecule-1 (ICAM-1) in non-Hodgkin lymphomas and leukaemias: possible influence on growth pattern and leukaemic behaviour. Clin Exp Immunol 1989; 77: 234-238.
9. Stauder R, Hamader S, Fasching B, Kemmler G, Thaler J, Huber H. Adhesion to high endothelial venules: a model for dissemination mechanisms in non-Hodgkin's lymphoma. Blood 1993; 82: 262-267.
10. Umetsu DT, Esserman L, Donlon TA, DeKruyff RH, Levy R. Induction of proliferation of human follicular (B type) lymphoma cells by cognate interaction with CD4 T cell clones. J Immunol 1990; 144: 2550-2557.
11. Böhmig CA, Kovarik J, Holter W, Pohanka E, Zlabinger GJ. Specific down-regulation of proliferative T cell alloresponsiveness by interference with CD2/LFA-3 and LFA-1/ICAM-1 in vitro. J Immunol 1994; 152: 3720-3728.
12. Clark EA, Ledbetter JA. How B and T cells talk to each other. Nature 1994; 367: 425-428.
13. Damle NK, Klussman K, Linsley PS, Aruffo A. Differential costimulatory effects of adhesion molecules B7, ICAM-1, LFA-3, and VCAM-1 on resting and antigen-primed CD4+ T lymphocytes. J Immunol 1992; 148: 1985-1992.
14. Makgoba MW, Sanders ME, Shaw S. The CD2-LFA3 and LFA1-ICAM pathways: relevance to T cell recognition. Immunol Today 1989; 10: 417-422.
15. Padros MR, Noli MI, Fainboim L. Expression of ICAM-1 (CD54) on normal and leukaemia B cells: implication for the mixed lymphocyte reaction. Clin Exp Immunol 1992; 88: 329-334.
16. Petrash S, Kosco M, Schmitz J, Wacker HH, Brittinger G. Follicular dendritic cells in non Hodgkin lymphoma express adhesion molecules complementary to ligands on neoplastic B cells. Br J Haematol 1992; 82: 695-700.
17. Steward M, Thiel M, Hogg N. Leucocyte integrins. Curr Opin Cell Biol 1995; 7: 690-696.
18. Burton GF, Conrad DH, Szakal AK, Tew JG. Follicular dendritic cells and B cell costimulation. J Immunol 1993; 150: 31-38.
19. Tohma S, Hirohata S, Lipsky PE. The role of CD11 a/CD18-CD54 interactions in human T cell dependent B cell activation. J Immunol 1991; 146: 492-499.
20. Emilie D, Wallon C, Galanaud P, Fisher A, Olive D, Delfraissy JF. Role of LFA3-CD2 interaction in human specific B cell differentiation. J Immunol 1988; 141: 1912-1918.
21. Koopman G, Keehnen RMJ, Lindhout E, Newman W, Shimizu Y, Van Seventer GA, De Groot C, Pals ST. Adhesion through LFA-1 (CD11a/CD18)-ICAM-1 (CD54) and the VLA-4 (CD49d)-VCAM-1 (CD106) pathways prevents apoptosis of germinal center B cells. J Immunol 1994; 152: 3760-3767.
22. Chaperot L, Jacob M-C, Le Vacon F, Giroux C, Molens J-P, Sotto J-J, Bensa J-C, Plumas J. Relationships between susceptibility to LAK cell-mediated lysis, conjugate formation and adhesion molecules expression in non Hodgkin's lymphomas. Leuk Lymphoma 1997; 28: 133-143.
23. Nakamura T, Takahashi K, Fukaszawa T, Koyanagi M, Yokoyama A, Kato H, Yagita H, Okumura K. Relative contribution of CD2 and LFA-1 to murine T and natural killer cell functions. J Immunol 1990; 145: 13628-13634.
24. Dawson CD, Scheppler JA, Nicholson JKA, Holman RC. Enumeration of antigen sites by flow cytometry. Pathobiol 1991; 59: 57-61.
25. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, lsaacson PG, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA. A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 1994; 84: 1361-1392.
26. Jacob MC, Favre M, Bensa JC. Membrane cell permeabilisation with saponin and multiparametric analysis by flow cytometry. Cytometry 1991; 12: 550-558.
27. Plumas J, Chaperot L, Jacob MC, Giroux C, Mollens JP, Sotto JJ, Bensa JC. Malignant B lymphocytes induce allogeneic proliferative and cytotoxic T cell responses in primary mixed lymphocyte cultures. Eur J Immunol 1995; 25: 3332-3341.
28. Chaperot L, Plumas J, Jacob MC, Bost F, Molens JP, Sotto JJ, Bensa JC. Fonctionnal expression of CD80 and CD86 allows immunogenicity of malignant cells from non-Hodgkin's lymphomas. Exp Hematol 1999; 27: 479-488.
29. Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983; 31: 13-20.
30. Varner JA, Cheresh DA. Integrins and cancer. Curr Opin Cell Biol 1996; 8: 727-730.
31. Boyd AW, Dunn SM, Fecondo JV, Culvenor JG, Dührsen GF, Burns GF, Wawryk S. Regulation of expression of a human intercellular adhesion molecule (ICAM-1) during lymphohematopoietic differentiation. Blood 1989; 73: 1896-1903.
32. Erikstein BK, Holte H, Kvaloy S, Andersson KB, Steen HB, Hannisdal E, Smeland EB. Expression of CD18 (integrin β2 chain) correlates with prognosis in malignant B cell lymphomas. Br J Haematol 1993; 83: 392-398.
33. Pinto A, Carbone A, Gloghini A, Marotta G, Volpe R, Zagonel V. Differential expression of cell adhesion molecules in B-zone small lymphocytic lymphoma and other well-differentiated lymphocytic disorders. Cancer 1993; 72: 894-904.
34. Hummel M, Tamaru J-I, Kalvelage B, Stein H. Mantle cell (previously centrocytic) lymphomas express VH genes with no or very little somatic mutations like the physiologic cells of the follicle mantle. Blood 1994; 84: 403-407.
35. Pratt LF, Rassenti L, Larrick J, Robbins B, Banks PM, Kipps TJ. Ig V region gene expression in small lymphocytic lymphoma with little or no somatic hypermutation. J Immunol 1989; 143: 699-705.
36. Zelenetz AD, Chen TT, Levy R. Clonal expansion in follicular lymphoma occurs subsequent to antigenic selection. J Exp Med 1992; 176: 1137-1148.
37. Maio M, Pinto A, Carbone A, Zagonel V, Gloghini A, Marotta G, Cirillo D, Colombatti A, Ferrara F, Del Vecchio L, Ferrone S. Differential expression of CD54/intercellular adhesion molecule-1 in myeloid leukemias and in lymphoproliferative disorders. Blood 1990; 76: 783-790.
38. Johnson JP. Cell adhesion molecules of the immunoglobulin supergene family and their role in malignant transformation and progression to metastic disease. Cancer Metast Rev 1991; 10: 11-22.
39. Tomita Y, Watanabe H, Kobayashi H, Nishiyama T, Tsuji S, Imai K, Abo T, Fujiwara M, Sato S. Expression of intercellular adhesion molecule-1 on transitional cell cancer. Possible significance in immunity against tumor cells. Am J Pathol 1993; 143: 191-198.
40. Ahsmann JM, Lokhors HM, Dekker AW, Bloem AC. Lymphocyte function-associated antigen-1 expression on plasma cells correlates with tumor growth in multiple mlyeloma. Blood 1992; 79: 2068-2075.
41. Inghirami G, Wieczorek R, Zhu BY, Silber R, Dalla-Favera R, Knowles DM. Differential expression of LFA-1 molecules in non Hodgkin's lymphoma and lymphoid leukemia. Blood 1988; 72: 1431-1434.
42. Gregory CD, Murray RJ, Edwards CF, Rickinson AB. Down regulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance. J Exp Med 1988; 167: 1811-1824.
43. Azuma A, Yagita H, Matsuda H, Okumura K, Niitani H. Induction of intercellular adhesion molecule 1 on small cell lung carcinoma cell lines by γ-interferon enhances spontaneous and bispecific anti-CD3 × antitumor antibody-directed lymphokine-activated killer cell cytotoxicity. Cancer Res 1992; 52: 4890-4894.
44. Jansen JH, Van Der Harst D, Wientjens GJHM, Kooy-Winkelaar YMC, Brand A, Willemze R, Kluin Nelemans HC. Induction of CD11a/leukocyte function antigen-1 and CD54/intercellular adhesion molecule-1 on hairy cell leukemia cells is accompagnied by enhanced susceptibility to T cell but not lymphokine-activated killer cell cytotoxicity. Blood 1992; 80: 478-483.
45. Roos E. Adhesion molecules in lymphoma metastasis. Cancer Metast Rev 1991; 10: 33-48.
46. Klein B, Zhang XG, Lu ZY, Bataille R. Interleukin-6 in human multiple myeloma. Blood 1995; 85: 863-872.
47. Emilie D, Coumbaras J, Raphael M, Devergne O, Delecluse HJ, Gisselbrecht C, Michiels JF, Van Damme J, Taga T, Kishimoto T, Crevon MC, Galanaud P. Interleukin-6 production in high-grade lymphomas: correlation with the presence of malignant immunoblasts in acquired immunodeficiency syndrome and in human immunodeficiency virus-seronegative patients. Blood 1992; 80: 498-504.